HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hydroxysafflor yellow A exerts neuroprotective effects in cerebral ischemia reperfusion-injured mice by suppressing the innate immune TLR4-inducing pathway.

Abstract
The innate immune response, which is tightly regulated by Toll-like receptor 4 (TLR4) pathway, has been shown to play a critical role in brain damage following cerebral ischemia-reperfusion injury. Hydroxysafflor yellow A (HSYA) is the active component extracted from the Flos Carthami and has been reported to decrease neurological deficit scores following ischemia-reperfusion injury. However, the precise mechanism by which it exerts these neuroprotective effects remains poorly understood. In this study, we demonstrated that the administration of HSYA could significantly down-regulate TLR4 expression in middle cerebral artery occlusion (MCAO) mice. Following the down-regulation of TLR4 by HSYA treatment, cerebral infarction and inflammatory neuronal damage was alleviated. The number of apoptotic neurons in the HSYA-treated group was significantly decreased along with the decrease in TLR4 expression in MCAO mice. Activation of the NF-κB and MAPK signaling pathways was observed at 1h following ischemia and at 24h post-reperfusion. HSYA could significantly inhibit NF-κB p-p65, ERE1/2, JNK and p38 phosphorylation, which coincided with the suppressed secretion of inflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and nitric oxide (NO). Moreover, brain-derived neurotrophic factor (BDNF) was up-regulated following 1h of ischemia and continued to increase initially during reperfusion but was down-regulated at later stages. Following treatment with HSYA, BDNF was up-regulated relative to control MCAO mice at 1h post-ischemia and at 12 and 24h post-reperfusion. Our data suggest that HSYA exerts neurotrophic and anti-inflammatory functions against ischemic stroke by inhibiting TLR4 pathway-mediated signaling responses.
AuthorsYanni Lv, Yisong Qian, Longsheng Fu, Xuanying Chen, Haili Zhong, Xiaohua Wei
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 769 Pg. 324-32 (Dec 15 2015) ISSN: 1879-0712 [Electronic] Netherlands
PMID26607471 (Publication Type: Journal Article)
CopyrightCopyright © 2015 Elsevier B.V. All rights reserved.
Chemical References
  • Brain-Derived Neurotrophic Factor
  • NF-kappa B
  • Neuroprotective Agents
  • Quinones
  • Tlr4 protein, mouse
  • Toll-Like Receptor 4
  • hydroxysafflor yellow A
  • Chalcone
  • Mitogen-Activated Protein Kinases
Topics
  • Animals
  • Brain-Derived Neurotrophic Factor (metabolism)
  • Chalcone (analogs & derivatives, pharmacology, therapeutic use)
  • Immunity, Innate (drug effects)
  • Infarction, Middle Cerebral Artery (complications)
  • Mice
  • Mitogen-Activated Protein Kinases (metabolism)
  • NF-kappa B (metabolism)
  • Neuroprotective Agents (pharmacology, therapeutic use)
  • Quinones (pharmacology, therapeutic use)
  • Reperfusion Injury (complications, drug therapy, metabolism, pathology)
  • Signal Transduction (drug effects, immunology)
  • Toll-Like Receptor 4 (metabolism)
  • Up-Regulation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: